Abstract B126: Correlation of tumor growth inhibition by check point inhibitors with PD-L1 expression in preclinical patient derived xenograft (PDX) models | Citedby Results | Cancer Immunology Research | American Association for Cancer Research

Skip to Main Content

Skip Nav Destination

Abstract B126: Correlation of tumor growth inhibition by check point inhibitors with PD-L1 expression in preclinical patient derived xenograft (PDX) models

Cancer Immunol Res (2016) 4 (11_Supplement): B126.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Patient-derived xenograft (PDX) models, applications and challenges in cancer research

Shahrokh Abdolahi
Zeinab Ghazvinian
Samad Muhammadnejad
Mahshid Saleh
Hamid Asadzadeh Aghdaei
Kaveh Baghaei

Journal of Translational Medicine (2022) 20 (1)